News|Articles|July 4, 2026
First Half 2026 Recap - Endocrinology
Author(s)Ryan Livingston
Fact checked by: Abigail Brooks, MA
Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 6 months.
Advertisement
Advertisement
Endocrinology saw significant advancements throughout the first 6 months of 2026, between major approvals from the US Food and Drug Administration (FDA) and key trial readouts regarding everything from obesity to type 1 (T1D) and type 2 diabetes (T2D).
Advertisement
Advertisement